Search

everythinglearnresearchcommunity

for

Search:↓

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

A rare form of lupus can cause severe nerve damage and other symptoms, but treatment can help.

Accurate diagnosis of SLE requires extensive testing due to its complex symptoms.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Hair loss in lupus patients indicates higher disease activity.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

New insights in skin conditions show a complex link between certain moles and melanoma, improved hair loss treatments, and the need to identify different types of lupus.

Early identification of lupus through skin signs and blood tests is crucial in India.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

A child with low platelets and anemia was later found to have lupus.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

SLE significantly affects daily life, especially through fatigue and joint pain, highlighting the need for better treatments.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.